Ontology highlight
ABSTRACT:
SUBMITTER: Kohler S
PROVIDER: S-EPMC6324074 | biostudies-literature | 2019 Jan
REPOSITORIES: biostudies-literature
Köhler Sebastian S Carmody Leigh L Vasilevsky Nicole N Jacobsen Julius O B JOB Danis Daniel D Gourdine Jean-Philippe JP Gargano Michael M Harris Nomi L NL Matentzoglu Nicolas N McMurry Julie A JA Osumi-Sutherland David D Cipriani Valentina V Balhoff James P JP Conlin Tom T Blau Hannah H Baynam Gareth G Palmer Richard R Gratian Dylan D Dawkins Hugh H Segal Michael M Jansen Anna C AC Muaz Ahmed A Chang Willie H WH Bergerson Jenna J Laulederkind Stanley J F SJF Yüksel Zafer Z Beltran Sergi S Freeman Alexandra F AF Sergouniotis Panagiotis I PI Durkin Daniel D Storm Andrea L AL Hanauer Marc M Brudno Michael M Bello Susan M SM Sincan Murat M Rageth Kayli K Wheeler Matthew T MT Oegema Renske R Lourghi Halima H Della Rocca Maria G MG Thompson Rachel R Castellanos Francisco F Priest James J Cunningham-Rundles Charlotte C Hegde Ayushi A Lovering Ruth C RC Hajek Catherine C Olry Annie A Notarangelo Luigi L Similuk Morgan M Zhang Xingmin A XA Gómez-Andrés David D Lochmüller Hanns H Dollfus Hélène H Rosenzweig Sergio S Marwaha Shruti S Rath Ana A Sullivan Kathleen K Smith Cynthia C Milner Joshua D JD Leroux Dorothée D Boerkoel Cornelius F CF Klion Amy A Carter Melody C MC Groza Tudor T Smedley Damian D Haendel Melissa A MA Mungall Chris C Robinson Peter N PN
Nucleic acids research 20190101 D1
The Human Phenotype Ontology (HPO)-a standardized vocabulary of phenotypic abnormalities associated with 7000+ diseases-is used by thousands of researchers, clinicians, informaticians and electronic health record systems around the world. Its detailed descriptions of clinical abnormalities and computable disease definitions have made HPO the de facto standard for deep phenotyping in the field of rare disease. The HPO's interoperability with other ontologies has enabled it to be used to improve d ...[more]